Erythrophagocytosis in Dermatitis Ulcerosa (Pyoderma Gangrenosum)
DOI:
https://doi.org/10.5644/Radovi.152Abstract
There are various names to be found in the medical literature for the same cutaneous disorder with its distinctive morphologic features well recognized as an clinical entity and at present mostly called Pyoderma gangrenosum (Brunsting, Goeakerman a. O’Leary6) or Dermatitis ulcerosa (Kresbach”)-
In this report the term Dermatitis ulcerosa is suggested as the most appropriate since it does not prejudice the etiopatogenecity of the disease which is not known and there is very low indication that the pyogenic infection is the main etiological factor.
Two female patients with classical clinical picture of Dermatitis ulcerosa and typical course of the disease were studied to broaden the concept of this rather vague disorder.
One of the patients had associated colitis ulcerosa and visceral candidiasis (candida albicans). To our experience this condition could not be considered as necessarily related to dermatitis ulcerosa and even less caused by it.
In the other patient no such or any other associated disorder were found.
The very extensive laboratory investigations could not reveal any conclusive finding which could be regarded as specific for dermatitis ulcerosa. Also, the histopathology demonstrated only the usually structures suggestive of the diagnosis.
Antibiotic treatment remained ineffective. However, steroids brought about complete involution of the lesions.
Also, in our patients the initial lesion was sterile showing in the native preparation besides cellular elements (macrophages and other) free lying elastic fibres from the destroyed tissue (illustrated by fig. 4).
It is interesting to note that the lesions in dermatitis ulcerosa — contrary to the normal wound healing — begun to heal (epithelise) in the rule in the central part of the lesion progressing to the periphery though sometimes the borders of the lesion are still in active extension.
The extension of the lesion or recurrences after complete healing \vas always going from the border to further periphery and never back to the area of the previously ulcerated skin this circumstance may indicate that an immunological mechanism might be involved (skin specific hypersensitivity).
The most peculiar findings in the report relate to the phenomenon of erythrophagocytosis which could be seen in the native preparations and Giemsa strained smears in material taken from the active lesions particularly from the peripheral borders in extension.
The macrophages seen in this material may contain numerous erythrocytes which appear to be intact and have been phagocytised whole rather than after rupture. Sometimes there could be observed in the native preparation erythrophagocytosis at different stages of the active process of phagocytosis as adherence of erythrocytes (occasionally becoming elongated) to the phagocyte, then becoming surrounded and drown into the macrophage (illustrated by fig. 5—10).
In peripheral blood smears erythrophagocytosis could not be observed in the reported patients.
This phenomenon which to our knowledge has not previously been recorded in dermatitis ulcerosa (Pyoderma gangrenosum and other denotation for the same disorder) is suggested to be a process of tissue mediated immunological mechanism.
In discussing the presumptive etiopathogenetic factors of dermatitis ulcerosa an immunological mechanism seems to be indicated although no sufficient proved evidence as reflected by altered immunoglobulin classes or respective antibodies is at present available.
References
Ayres S. Jr., Ayres III. S.; Pyoderma gangrenosum with an Unusual Syndrome of Ulcers, Vesicles and Arthritis. Arch. Derm., 77: 269—280 (1958).
Bauer F. M., and Hewitt L. W.: Pseudomonas Aeruginosa contaminant or Patogen. Arch. Derm., 84: 410—418 (1961).
Bloom D., Fischer D., and Dannenberg M.: cit Jablonska. Pyoderma Gangrenosum. Hautarzt 15, Hft. 11: 584-—591 (1964).
Bluefarb M. S., Rodin H. H., and Hoit L.: Pyoderma Gangrenosa. Arch. Derm., 71: 750—751 (1955).
Bucholz W.: Dermatitis ulcerosa der Axillar und Genitoanalregion mit Polyarthritis und temporarem IgM — Mangel. Z. Haut-Gesch. Kr., 45, 24: 995—1004 (1969).
Brunsting L. A., Goeckerman W. H., and O'leary P. A.: Pyoderma (Ecthyma) Gangrenosum. Arch. Derm., 22: 655 (1930).
Coombs R. R. A.: Immune Phenomenon in (Relation to ithe Skin in Progr. in the Biol. Scienc. in Relation to Đermatol., Ed. A. ROOK, Cambridge University pres, 1960: 247.
Guller R.: Postoperative Progressive Gangran und Dermatitis ulcerosa. Hautarzt 19: 408-422 (1968).
Jablonska S.: Zur Pathogenese des Pyoderma Gangrenosum. Hautarzt 15: 584—591 (1964).
Kogoj Fr.: Kroničke piodermije. (Predavanje održano u Fiuggi-Dies Italico-Yugoslavici medicinae distinati 12—14 IX. 1969 — u štampi).
Kogoj F r.: Uber Chronische Pyodermien. Wiener Med. Wschr., 41/42 : 850—854 (1960).
Kresbach H.: Ein Beitrag zum Problem der sogenannten Pyodermia ulcerosa. Arch. klin. exp. Derm., 208: 128—159 (1959).
Long P. I., and Uesu C. T.: Pyoderma gangrenosum. JAMA, 187: 336—339 (1964).
Marcussen P. V.: Hypogammaglobulinemia in Pyoderma gangraenosum. J. invest. Derm., 24: 275—280 (1955).
Orfuss A. J., and Allen E.: Pyoderma gangrenosum. Arch. Derm., 81: 179/483—180/484 (1960).
Pereival G. H.: Pyoderma Gangrenosum the Histology of 'the primary Lesion. Brit. J. Derm., 69: 130 (1957).
Perry H. D., and Brunsting L. A.: Pyoderma Gangraenosum. Arch. Derm. Syph. (Chicago) 75: 380—386 (1957).
Perry H. O., and Didisheim P.: Consideration of the Etiology of Pyoderma Gangrenosum. XIII Congressus Internationalis Dermatologiae. Miinchen 1967. Ed. W. Jadassohn a. C. G. Schirren, Spring-Verlag-Berlin, Berlin, Heidelberg, New Yonk. 1968: 1208.
Perlmann P., and Broberger O.: Lower Gastrointestinal System. In Textbook of Immunopathology, Ed. Miescher P. A., and Miiller-Eberhard, H. J. Vol. II: 44, Grune a. Stratton, New York a. London, 1969.
Rockl H.: Hdb. Haut u. Gschl., J. Jadassohn: Pyodermien. Erguanz, ! Bd. IV/1, A, S. 131, Springer 1964.
Rockl H., Knedel M., und Schropl F.: Uber das Vorkommen von Paraproteinamie bei Pyodermia ulcerosa serpiginasa (Pyoderma gangraenosum, Dermatitis ulcerosa). Hautarzt 15: 165—171 (1964).
Salfeld K.: Pyoderma gangraenosum und Erkrankungen an inneren Organen. Gleichzeitig ein Beitrag zur Pathogenese. Derm. Wschr., 149: 425—437 (1964).
Schirren C., und Walther L.: Zur Klinik und Therapie der Pyodermia ulcerosa serpiginosa. Hautarzt 16: 552—557 (1965).
Schopf E., Schulz H. J., und Schulz K. H.: Azathioprin — Behandlung der Dermatitis ulcerosa (Pyoderma gangrenosum). Hautarzt 20: 558—563 (1969).
Schuppli R., und Birkhauser H.: Ein Fali von Pyoderma gangraenosum mit Lungenveranderungen. Dermatologica (Basel) 115: 648 — 655 (1957).
Sloan jr. W. P., and Cow.: Life histories of patients with chr. ulc. col. Gastroenterology, 16: 25 (1950), cit. po L4.
Van Der Sluis I.: Two Cases of Pyoderma (Ecthyma) Gangraenosum associated with the Presence of an abnormal Serumprotein (beta 2-A-Paraprotein). Dermatologica (Basel) 133: 409—424 (1966).
Williams jr., H. M., und Stone O. J.:. Blastomycosis like Pyoderma. Arch. Derm., 93: 226—228 (1966).
Wright R.: Auto-immunity and the Gastrointestinal tract. Practitioner. 199: 167 (1967).
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ernest I. Grin, Vera Tadić-Tigerman

This work is licensed under a Creative Commons Attribution 4.0 International License.


